205
Views
7
CrossRef citations to date
0
Altmetric
Article

Label-free sensitive detection of MUC1 using a liquid crystal based-system

&
Pages 1784-1793 | Received 08 Nov 2019, Accepted 10 Feb 2020, Published online: 17 Feb 2020

References

  • Tanimoto T, Haruma K. MUC1 expression in intramucosal colorectal neoplasms. Oncology. 1999;734:223–231.
  • Hayes BDF, Mesa-tejada R, Papsidero LD, et al. Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a cancer and leukemia group B study. J Clin Oncol. 2019;9:1113–1123.
  • Maeshima A, Miyagi A, Hirai T. Mucin‐producing adenocarcinoma of the lung, with special reference to goblet cell type adenocarcinoma: immunohistochemical observation and Ki‐ras gene mutation. Path Int. 1997;47:454–460.
  • Zhang S, Scher I. Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers. Clin Cancer Res. 1998;4:295–302.
  • Burdick MD, Harris A, Reid CJ, et al. Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines. J Biol Chem. 1997;272:24198–24202.
  • Haruma K. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer. Oncology. 1998;734:307–319.
  • Nacht M, Ferguson AT, Zhang W, et al. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res. 1999;59:5464–5470.
  • Walsh MD, Devine PL, Gardiner RA. Mucin expression by transitional cell carcinomas of the bladder. Brit J Urol. 1994;73:256–262.
  • Barratt-Boyes SM. Making the most of mucin: a novel target for tumor immunotherapy. Cancer Immune Immuno. 1996;43:142–151.
  • Beatty P, Hanisch FG, Stolz DB, et al. Biochemical characterization of the soluble form of tumor antigen MUC1 isolated from sera and ascites fluid of breast and pancreatic cancer patients. Clin Cancer Res. 2001;7:781–788.
  • Creaney J, Segal A, Sterrett G, et al. Overexpression and altered glycosylation of MUC1 in malignant mesothelioma. Br J Cancer. 2008;98:1562–1569.
  • Song J, Zhou Y, Chen B, et al. Development of electrochemical aptamer biosensor for tumor marker MUC1 determination. Int J Electrochem Sci. 2017;12:5618–5628.
  • Fragoso A, Latta D, Laboria N, et al. Integrated microfluidic platform for the electrochemical detection of breast cancer markers in patient serum samples. Lab Chip. 2011;11:625–631.
  • Taylor-Papadimitriou J, Burchell J, Miles DW, et al. MUC1 and cancer. Bioch Bioph Acta (BBA)-Mol Basis Dis. 1999;1455:301–313.
  • Burchell J, Wang D, Taylor‐Papadimitriou J. Detection of the tumour‐associated antigens recognized by the monoclonal antibodies hmfg‐1 and 2 in serum from patients with breast cancer. Int J Cancer. 1984;34:763–768.
  • Hanisch FG, Müller S. MUC1: the polymorphic appearance of a human mucin. Glycobiology. 2000;10:439–449.
  • Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990;346:818–822.
  • Ellington AD. Anti-peptide aptamers recognize amino acid sequence and bind a protein epitope. Proc Natl Acad Sci. 1996;93:7475–7480.
  • Jiang X, Wang H, Wang H, et al. Electrochemiluminescence biosensor based on 3-D DNA nanomachine signal probe powered by protein-aptamer binding complex for ultrasensitive mucin 1 detection. Anal Chem. 2017;89:4280–4286.
  • Cheng AKH, Su H, Wang YA, et al. Aptamer-based detection of epithelial tumor marker mucin 1 with quantum dot-based fluorescence readout. Anal Chem. 2009;8:6130–6139.
  • Li C, Meng Y, Wang S, et al. Mesoporous carbon nanospheres featured fluorescent aptasensor for multiple diagnosis of cancer in vitro and in vivo. ACS Nano. 2015;9:12096–12103.
  • Zhang Y, Guo S, Huang H, et al. Silicon nanodot-based aptasensor for fluorescence turn-on detection of mucin 1 and targeted cancer cell imaging. Anal Chim Acta. 2018;1035:154–160.
  • Chen X, Zhang Q, Qian C, et al. Electrochemical aptasensor for mucin 1 based on dual signal amplification of poly(o-phenylenediamine) carrier and functionalized carbon nanotubes tracing tag. Biosens Bioelectron. 2014;64:485–492.
  • Liu S, Xu N, Tan C, et al. A sensitive colorimetric aptasensor based on trivalent peroxidase-mimic DNAzyme and magnetic nanoparticles. Anal Chim Acta. 2018;1018:86–93.
  • Huang RC, Chiu WJ, Po-Jung Lai I, et al. Multivalent aptamer/gold nanoparticle–modified graphene oxide for mass spectrometry–based tumor tissue imaging. Sci Rep. 2015;5:1–10.
  • Tian T, Hu Q, Wang Y, et al. Effect of imidazolium-based surface-active ionic liquids on the orientation of liquid crystals at various fluid/liquid crystal interfaces. Langmuir. 2016;32:11745–11753.
  • Park SJ, Min J, Hu QZ, et al. Detection of mRNA from Escherichia coli in drinking water on nanostructured polymeric surfaces using liquid crystals. Colloid Polym Sci. 2014;292:1163–1169.
  • Lee MJ, Lee W. Liquid crystal-based capacitive, electro-optical and dielectric biosensors for protein quantitation. Liq Cryst. 2019;1–9.
  • Hu QZ, Jang CH. Using liquid crystals to report molecular interactions between cationic antimicrobial peptides and lipid membranes. Analyst. 2012;137:567–570.
  • Zhao J, Chen C, Zhang L, et al. An electrochemical aptasensor based on hybridization chain reaction with enzyme-signal amplification for interferon-gamma detection. Biosens Bioelectron. 2012;36:129–134.
  • Liu J, Cao Z, Lu Y. Functional nucleic acid sensors. Chem Rev. 2009;109:1948–1998.
  • Kim H, An Z, Jang CH. Label-free optical detection of thrombin using a liquid crystal-based aptasensor. Microchem J. 2018;141:71–79.
  • Kim HJ, Jang CH. Liquid crystal-based aptasensor for the detection of interferon-Γ and its application in the diagnosis of tuberculosis using human blood. Sens Actuators B Chem. 2019;282:574–579.
  • Zhong S, Jang CH. Nematic liquid crystals confined in microcapillaries for imaging phenomena at liquid-liquid interfaces. Soft Matter. 2015;11:6999–7004.
  • Ferreira CSM, Papamichael K, Guilbault G, et al. DNA aptamers against the MUC1 tumour marker: design of aptamer-antibody sandwich ELISA for the early diagnosis of epithelial tumours. Anal Bioanal Chem. 2008;390:1039–1050.
  • Guo P, Xiong J, Zheng D, et al. A biosensor based on a film bulk acoustic resonator and biotin-avidin system for the detection of the epithelial tumor marker mucin 1. RSC Adv. 2015;5:66355–66359.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.